Diabetes Health Center
Type 1 Diabetes - Other Places To Get Help
Organizations
| American Diabetes Association (ADA) | |
| 1701 North Beauregard Street | |
| Alexandria, VA 22311 | |
| Phone: | 1-800-DIABETES (1-800-342-2383) |
| E-mail: | AskADA@diabetes.org |
| Web Address: | www.diabetes.org |
|
The American Diabetes Association (ADA) is a national organization for health professionals and consumers. Almost every state has a local office. ADA sets the standards for the care of people with diabetes. Its focus is on research for the prevention and treatment of all types of diabetes. ADA provides patient and professional education mainly through its publications, which include the monthly magazine Diabetes Forecast, books, brochures, cookbooks and meal planning guides, and pamphlets. ADA also provides information for parents about caring for a child with diabetes. |
|
|
|
|
| Juvenile Diabetes Research Foundation International | |
| 120 Wall Street | |
| New York, NY 10005-4001 | |
| Phone: | 1-800-533-CURE (1-800-533-2873) |
| Fax: | (212) 785-9595 |
| E-mail: | info@jdrf.org |
| Web Address: | http://www.jdrf.org |
|
The Juvenile Diabetes Research Foundation International is dedicated to finding a cure for type 1 diabetes and its complications. The organization funds research on type 1 diabetes, including research on prevention and treatment. This organization publishes a wide variety of booklets, magazines, and e-newsletters on complications and treatments of type 1 diabetes. |
|
|
|
|
| National Diabetes Education Program (NDEP) | |
| 1 Diabetes Way | |
| Bethesda, MD 20814-9692 | |
| Phone: | 1-800-438-5383 to order materials (301) 496-3583 |
| E-mail: | ndep@mail.nih.gov |
| Web Address: | http://ndep.nih.gov |
|
The National Diabetes Education Program (NDEP) is sponsored by the U.S. National Institutes of Health (NIH) and the U.S. Centers for Disease Control and Prevention (CDC). The program's goal is to improve the treatment of people who have diabetes, to promote early diagnosis, and to prevent the development of diabetes. Information about the program can be found on two Web sites: one managed by NIH (http://ndep.nih.gov) and the other by CDC (www.cdc.gov/team-ndep). |
|
|
|
|
| National Diabetes Information Clearinghouse (NDIC) | |
| 1 Information Way | |
| Bethesda, MD 20892-3560 | |
| Phone: | 1-800-860-8747 |
| Fax: | (703) 738-4929 |
| TDD: | 1-866-569-1162 toll-free |
| E-mail: | ndic@info.niddk.nih.gov |
| Web Address: | http://diabetes.niddk.nih.gov |
|
This clearinghouse provides information about research and clinical trials supported by the U.S. National Institutes of Health. This service is provided by the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), a part of the National Institutes of Health (NIH). |
|
|
|
|
WebMD Medical Reference from Healthwise
Type 1 Diabetes Topics
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Please see UROXATRAL full prescribing information.
Vinegar is in everything from coleslaw to pickles. What if you could actually use it to help prevent disease?
